Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ)
CNY 14.75
(0.07%)
CNY 14.75
(0.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.17 Billion | 1.95 Billion | 1.74 Billion | 1.56 Billion | 1.64 Billion | 1.58 Billion |
| Cost of Revenue | 602.56 Million | 568.78 Million | 447.09 Million | 448.86 Million | 445.25 Million | 432.42 Million |
| Gross Profit | 1.56 Billion | 1.39 Billion | 1.29 Billion | 1.11 Billion | 1.19 Billion | 1.15 Billion |
| Operating Expenses | 1.06 Billion | 982.55 Million | 884.15 Million | 781.63 Million | 728.47 Million | 653.86 Million |
| Selling, General and Administrative Expenses | 786.71 Million | 600.93 Million | 606.41 Million | 536.65 Million | 529.42 Million | 482.04 Million |
| Research and Development Expenses | 158.06 Million | 217.03 Million | 202.44 Million | 154.28 Million | 104.11 Million | 64.66 Million |
| Other Expenses | -27.96 Million | 164.58 Million | 75.28 Million | 90.69 Million | 94.94 Million | -2.57 Million |
| Cost and Expenses | 1.65 Billion | 1.55 Billion | 1.33 Billion | 1.23 Billion | 1.17 Billion | 1.08 Billion |
| Operating Income | 518.26 Million | 446.78 Million | 429.03 Million | 354.73 Million | 469.41 Million | 498.25 Million |
| Interest Expense | 16.35 Million | 20.23 Million | 18.21 Million | 11.55 Million | 5.57 Million | 5.4 Million |
| Income Tax Expense | 96.98 Million | 116.65 Million | 85.33 Million | 67.14 Million | 75.49 Million | 82.33 Million |
| Earnings before Tax | 518.28 Million | 446.17 Million | 429.05 Million | 344.16 Million | 467.63 Million | 495.68 Million |
| Net Income | 421.29 Million | 329.52 Million | 343.71 Million | 277.02 Million | 392.14 Million | 413.34 Million |
| Earnings Per Share Basic | 0.72 | 0.56 | 0.60 | 0.48 | 0.67 | 0.70 |
| Earnings Per Share Diluted | 0.72 | 0.56 | 0.60 | 0.48 | 0.67 | 0.70 |
| Weighted Average Shares Outstanding | 585.13 Million | 587.56 Million | 575.27 Million | 575.27 Million | 585.28 Million | 590.49 Million |
| Weighted Average Shares Outstanding (Diluted) | 585.13 Million | 587.56 Million | 575.27 Million | 575.27 Million | 585.28 Million | 590.49 Million |
| Gross Margin | 0.72 | 0.71 | 0.74 | 0.71 | 0.73 | 0.73 |
| EBIT Margin | 0.30 | 0.29 | 0.32 | 0.28 | 0.34 | 0.37 |
| Profit Margin | 0.19 | 0.17 | 0.20 | 0.18 | 0.24 | 0.26 |
| EBITDA | 660.84 Million | 590.79 Million | 561.02 Million | 443.23 Million | 564.01 Million | 604.18 Million |
| Earnings Before Tax Margin | 0.24 | 0.23 | 0.25 | 0.23 | 0.29 | 0.31 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 506.37 Million | 585.82 Million | 482.58 Million | 539.98 Million | 2.17 Billion | 437.6 Million |
| Cost of Revenue | 126.2 Million | 145.68 Million | 124.3 Million | 155.17 Million | 586.4 Million | 111.99 Million |
| Gross Profit | 380.16 Million | 440.14 Million | 358.27 Million | 384.81 Million | 1.58 Billion | 325.6 Million |
| Operating Expenses | 276.83 Million | 216.61 Million | 223.19 Million | 501.29 Million | 1.65 Billion | 280.46 Million |
| Selling, General and Administrative Expenses | 358.13 Million | 129.31 Million | 193.83 Million | 176.46 Million | - | 315.65 Million |
| Research and Development Expenses | 35.81 Million | 45.94 Million | 33.08 Million | 52.72 Million | - | 41.33 Million |
| Other Expenses | -117.12 Million | -88.55 Thousand | -34.98 Thousand | -501.29 Million | -1.65 Billion | -438.91 Thousand |
| Cost and Expenses | 403.03 Million | 362.29 Million | 347.5 Million | 501.29 Million | 1.65 Billion | 392.45 Million |
| Operating Income | 109.73 Million | 228.02 Million | 127.22 Million | 38.68 Million | 516.6 Million | 44.06 Million |
| Interest Expense | 918.39 Thousand | 4.22 Million | 3.05 Million | -10.45 Million | 16.35 Million | 20.84 Million |
| Income Tax Expense | 26.95 Million | 26.98 Million | 27.17 Million | 16.3 Million | 96.98 Million | 26.26 Million |
| Earnings before Tax | 109.85 Million | 227.93 Million | 127.19 Million | 38.58 Million | 516.16 Million | 43.62 Million |
| Net Income | 82.9 Million | 200.95 Million | 100.01 Million | -6.14 Million | 421.29 Million | 17.35 Million |
| Earnings Per Share Basic | 0.14 | 0.34 | 0.17 | -0.01 | - | 0.03 |
| Earnings Per Share Diluted | 0.14 | 0.34 | 0.17 | -0.01 | - | 0.03 |
| Weighted Average Shares Outstanding | 587.56 Million | 588.33 Million | 588.33 Million | 581.85 Million | 585.13 Million | 587.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 587.56 Million | 588.33 Million | 588.33 Million | 581.83 Million | 585.13 Million | 587.56 Million |
| Gross Margin | 0.75 | 0.75 | 0.74 | 0.71 | 0.73 | 0.74 |
| EBIT Margin | 0.22 | 0.39 | 0.29 | 0.06 | - | 0.16 |
| Profit Margin | 0.16 | 0.34 | 0.21 | -0.01 | 0.19 | 0.04 |
| EBITDA | 110.77 Million | 228.17 Million | 139.2 Million | 29.78 Million | - | 69.22 Million |
| Earnings Before Tax Margin | 0.22 | 0.39 | 0.26 | 0.07 | 0.24 | 0.10 |
GOODN
FIZZ
QIA
603588
WRAP
600770